AtaiBeckley Inc. (ATAI)
NASDAQ
Delayed Data
Oct 22, 2026, 01:30 PM
Day's Range
0.641852 wk Range
0.6000Overview - ATAI - AtaiBeckley Inc.
Key Statistics
Valuation
Enterprise Value
2.50B
P/E (Trailing)
-0.32
P/E (Forward)
-15.31
PEG Ratio
0.0091
Price / Sales (TTM)
609.53
Price / Book
15.37
EV / EBITDA
-17.78
Profitability
Profit Margin
0.00%
Operating Margin
-2,590.43%
Return on Assets
-39.02%
Return on Equity
-417.20%
Ownership
Shares Outstanding
369.21M
Float
308.41M
Short % of Shares Outstanding
6.11%
Held by Insiders
2.18%
Held by Institutions
52.30%
Price stats
Beta
1.55
50-Day Avg
6.90
200-Day Avg
4.74
Dividends
Payout Ratio
0.00%
Analyst Consensus
13 analysts
Average price target
$ 8.10Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ATAI - AtaiBeckley Inc.
Peers - ATAI - AtaiBeckley Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- ATAINASDAQAtaiBeckley Inc.353.80MMarket Cap-572.96%52-week change-0.33P/E (Trailing)0.00%Profit Margin
- ARGXNASDAQArgenx SE51.51BMarket Cap-3.70%52-week change31.22P/E (Trailing)32.26%Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.31.02BMarket Cap-111.89%52-week change39.09P/E (Trailing)16.12%Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share22.03BMarket Cap-23.08%52-week change160.80P/E (Trailing)-63.63%Profit Margin
- ASNDNASDAQAscendis Pharma A/S14.82BMarket Cap+8.90%52-week change17.26P/E (Trailing)70.84%Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.12.97BMarket Cap+15.27%52-week change-17.56P/E (Trailing)-97.02%Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.10.58BMarket Cap+1.57%52-week change147.76P/E (Trailing)2.14%Profit Margin
Profile Summary - ATAI - AtaiBeckley Inc.
About
AtaiBeckley Inc. is a clinical-stage biopharmaceutical company focused on developing mental health treatments. The company concentrates on rapid-acting, durable, and convenient therapies designed to address difficult-to-treat psychiatric conditions, including depression, treatment-resistant depression, social anxiety…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
